Search research articles
Contact Us
Filters
Showing results (71-80 of 108) with videos related to
Page
of 11
Sort By:
Pediatric Blood & Cancer
|
March 5, 2019
Multidisciplinary surgical strategy for dumbbell neuroblastoma: A single-center experience of 32 cases
Luca Pio, Thomas Blanc, Timothé de Saint Denis, et al.
The Lancet. Oncology
|
November 30, 2019
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study
Birgit Geoerger, C Michel Zwaan, Lynley V Marshall, et al.
Plos One
|
September 26, 2017
Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival
Hervé J Brisse, Thomas Blanc, Gudrun Schleiermacher, et al.
Nature
|
October 17, 2008
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey, Delphine Lequin, Laurence Brugières, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Accumulation of segmental alterations determines progression in neuroblastoma
Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Agnès Ribeiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification
Bruno De Bernardi, Mary Gerrard, Luca Boni, et al.
Plos One
|
July 12, 2014
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN
Anne Guimier, Sandrine Ferrand, Gaëlle Pierron, et al.
Cancer
|
August 27, 2004
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification
Anne Laprie, Jean Michon, Olivier Hartmann, et al.
European Journal of Human Genetics : EJHG
|
May 1, 2018
Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients
Julien Masliah-Planchon, Dominique Lévy, Delphine Héron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Overall genomic pattern is a predictor of outcome in neuroblastoma
Isabelle Janoueix-Lerosey, Gudrun Schleiermacher, Evi Michels, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 108) with videos related to
Sort By:
Page
of 11
Pediatric Blood & Cancer
|
March 5, 2019
Multidisciplinary surgical strategy for dumbbell neuroblastoma: A single-center experience of 32 cases
Luca Pio, Thomas Blanc, Timothé de Saint Denis, et al.
The Lancet. Oncology
|
November 30, 2019
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study
Birgit Geoerger, C Michel Zwaan, Lynley V Marshall, et al.
Plos One
|
September 26, 2017
Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival
Hervé J Brisse, Thomas Blanc, Gudrun Schleiermacher, et al.
Nature
|
October 17, 2008
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey, Delphine Lequin, Laurence Brugières, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Accumulation of segmental alterations determines progression in neuroblastoma
Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Agnès Ribeiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification
Bruno De Bernardi, Mary Gerrard, Luca Boni, et al.
Plos One
|
July 12, 2014
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN
Anne Guimier, Sandrine Ferrand, Gaëlle Pierron, et al.
Cancer
|
August 27, 2004
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification
Anne Laprie, Jean Michon, Olivier Hartmann, et al.
European Journal of Human Genetics : EJHG
|
May 1, 2018
Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients
Julien Masliah-Planchon, Dominique Lévy, Delphine Héron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Overall genomic pattern is a predictor of outcome in neuroblastoma
Isabelle Janoueix-Lerosey, Gudrun Schleiermacher, Evi Michels, et al.
Page
of 11